Condition: Gastroesophageal Junction Adenocarcinoma · Hypofractionated Radiotherapy · Sponsor: West China Hospital
The purpose of this study is to investigate the safety and efficacy of HFRT plus neoadjuvant ICT in locally advanced resectable GEJA.
This description comes directly from the study's public registry record.
Yaqin Zhao Associate Chief Physician · +86 18628260828 · zhaoyaqin@163.com
Always discuss trial participation with your own doctor first.
| West China Xiamen Hospital, Sichuan University | Xiamen, Fujian, China | Recruiting |
| The Seventh People's Hospital of Chengdu | Chengdu, Sichuan, China | Recruiting |
| West China Hospital, Sichuan University | Chengdu, Sichuan, China | Recruiting |
| West China Shangjin Nanfu Hospital, Sichuan University | Chengdu, Sichuan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07182565